Cedric O'Gorman
Plus aucun poste en cours
Fortune : 47 063 $ au 31/03/2024
Profil
Cedric O'Gorman worked as Senior VP-Clinical Development & Medical Affairs at Axsome Therapeutics, Inc. from 2017 to 2021.
Prior to that, he was Vice President-Medical Affairs at Intra-Cellular Therapies, Inc. from 2014 to 2017.
He will be Chief Medical Officer at Relmada Therapeutics, Inc. in 2023 and was Chief Medical Officer at Alpha Cognition, Inc. from 2021 to 2023.
O'Gorman holds a doctorate from the National University of Ireland and an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC
0,03% | 23/05/2023 | 10 121 ( 0,03% ) | 47 063 $ | 31/03/2024 |
Anciens postes connus de Cedric O'Gorman
| Sociétés | Poste | Fin |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2024 |
| ALPHA COGNITION INC. | Chief Tech/Sci/R&D Officer | 06/01/2023 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/12/2021 |
| INTRA-CELLULAR THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 01/09/2017 |
Formation de Cedric O'Gorman
| National University of Ireland | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| RELMADA THERAPEUTICS, INC. | Health Technology |
| ALPHA COGNITION INC. | Health Technology |
